Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
[Comparative study of the placenta from HIV+ mothers. Ultrastructural analysis]
Ginecol Obstet Mex. 1996 Apr;64:167-76. Unique Identifier : AIDSLINE MED/96233329 Villegas-Castrejon H; Paredes-Vivas Y; Flores-Rivera E; Gorbea-Robles MC; Arredondo-Garcia JL; Instituto Nacional de Perinatologia, Mexico, D.F.
Abstract:
Perinatal vertical transmission has increased in all the world; it is considered that at the present time there are about one million of children with HIV. Variation goes from 12 to 40%, at different countries. During the last years antiretroviral drugs as AZT, ddI and others have been used to diminish the virus passage via transplacentary. Eighteen placentaes from HIV seropositive women, three corresponded to first trimester, and 15 to the third trimester of gestation; in four cases they were treated with AZT in weeks fourteen (two patients), 26 and 35 of gestation; and one patient received AZT and ddI at week 28. Control group was with ten normal placentaes. Ultraestructural analysis and immuno-peroxidase and immuno-oro with antibody anti gp 41, were done. Ultraestructurally there were different localizations of HIV virus, at sincitiotrophoblast, decidual cells and umbilical vessels (six cases). In 13 cases there was hyperplasia and hypertrophy of macrophages containing a great amount of lysosomes. In one case, where a girl was seropositive many viriones HIV, were identified in macrophages. With immuno-oro viral proteins were seen in cytoplasm an plasmatic membrane, in endothelium of fetal capillars and trophoblast. With immunoperoxidase, four cases were positive. Placentaes with antiretroviral treatment since week 14, trophoblast was more dense by philaments increment. Placentaes with treatment during the third trimester, showed normal morphology with slight increase of philaments. In the cases treated with AZT and ddI, there were not macrophages hyperplasia and hypertrophy, nor viral particles. It is concluded that in seropositive mothers without treatment, the virus may be present in any part of chorionic villi, and in patients with treatment, virus is not identified, but a viral proteins synthesis.
Keywords: Antiviral Agents/*THERAPEUTIC USE Comparative Study Didanosine/*THERAPEUTIC USE Disease Transmission, Vertical/*PREVENTION & CONTROL English Abstract Female Human HIV Infections/*PREVENTION & CONTROL/*TRANSMISSION HIV Seropositivity/*VIROLOGY Microscopy, Electron Placenta/ULTRASTRUCTURE/*VIROLOGY Pregnancy Pregnancy Complications, Infectious/*VIROLOGY Zidovudine/*THERAPEUTIC USE CLINICAL TRIAL JOURNAL ARTICLE 961130
M96B1829
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
